Bill Bell
Ophthalmology · Carlsbad, CANPI 1194913988
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $39,965 of the $62,374 with a category attached, or 64.1%. Sun Pharmaceutical Industries Inc. accounts for 61.2% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $42,911 and has fallen 99.1% since, to $404 in 2023. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $344.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$38K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$14K
- Eyevance Pharmaceuticals LLC$3K
- Bausch Health US, LLC$2K
- Aerie Pharmaceuticals, Inc.$607
- Oyster Point Pharma, Inc.$568
- plus $4K from 16 others
What the payments were for
- Consulting fees$7,96013%
- Speaking & faculty fees$39,96564%
- Travel & lodging$5,5919%
- Food & beverage$8,85714%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 52 | $38,166 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 30 | $14,116 |
| Eyevance Pharmaceuticals LLC | 20 | $2,815 |
| Bausch Health US, LLC | 1 | $2,440 |
| Aerie Pharmaceuticals, Inc. | 9 | $607 |
| Oyster Point Pharma, Inc. | 11 | $568 |
| AbbVie(2 entities) | 11 | $489 |
| Dompe US, Inc. | 5 | $474 |
| Shire North American Group Inc | 9 | $442 |
| Alcon | 9 | $418 |
| Kala Pharmaceuticals, Inc. | 5 | $368 |
| Bausch & Lomb Americas Inc. | 2 | $273 |
| Mallinckrodt Hospital Products Inc. | 3 | $254 |
| Rxsight Inc | 2 | $234 |
| Maculogix, Inc. | 2 | $177 |
| Sight Sciences, Inc. | 3 | $171 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $136 |
| Beaver-visitec International, Inc. | 1 | $103 |
| Optos, Inc. | 1 | $58 |
| Novartis | 1 | $24 |
| Mallinckrodt Enterprises LLC | 1 | $22 |
| Notal Vision, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CEQUA$20,206
- BROMSITE$17,228
- LOTEMAX SM$6,884
- BESIVANCE$5,302
- ZYLET$2,440
- BEPREVE$2,440
- ALREX$2,440
- Flarex$1,404
- Tobradex ST$1,200
- DOCTORS ALLERGY FORMULA$610
- Rhopressa$593
- XELPROS$483
- Rocklatan$368
- Oxervate$358
- VYZULTA$340
- TYRVAYA$307
- LUMIGAN$238
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$234
- ACTHAR$232
- AdaptDx$159
How this compares
$62,374 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.
Other ophthalmology in Carlsbad
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
- Srinivas SaddaPasadena$1M
- Sheri RowenNewport Beach$1M
- Savak TeymoorianLaguna Hills$955K
- Andrew MoshfeghiLos Angeles$895K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.